Next, using the BloodPool dataset from BloodSpot, we show that PCDH17 expression is significantly lower in patients with AML (n = 1825) in comparison to HSC (n = 6) and polymorphonuclear cell (PMN) (n = 3) from healthy donors (Fig. 2c). This evidence concerns the gene PCDH17 and acute myeloid leukemia.